DKN-01,Tislelizumab
Leap Therapeutics,BeiGene,Novartis
['dkn-01', 'tislelizumab', 'distinguish study', 'kn-01', 'gastric', 'beigene', 'leaptherap', 'leap therap']
today at #asco2023, updated data from part a of the distinguish study of dkn-01 + s tislelizumab + chemo in #gastriccancer was presented as a poster and in a discussion session. 
Leap Therapeutics is developing novel cancer drugs.